Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply

Marijke Linschoten; Janine Am Kamphuis; Folkert W Asselbergs

doi:https://doi.org/10.1016/S2352-3026(20)30228-3

Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply

Marijke Linschoten, Janine Am Kamphuis, Folkert W Asselbergs

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	e557-e558
Journal	Lancet. Haematology
Volume	7
Issue number	8
DOIs	https://doi.org/10.1016/S2352-3026(20)30228-3
Publication status	Published - Aug 2020
Externally published	Yes

Keywords

Cyclophosphamide
Doxorubicin
Humans
Lymphoma, Non-Hodgkin
Prednisone
Rituximab
Vincristine

Access to Document

https://doi.org/10.1016/S2352-3026(20)30228-3

Cite this

@article{a09146a04da44049bda8a6a5f6c34c60,

title = "Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply",

keywords = "Cyclophosphamide, Doxorubicin, Humans, Lymphoma, Non-Hodgkin, Prednisone, Rituximab, Vincristine",

author = "Marijke Linschoten and Kamphuis, {Janine Am} and Asselbergs, {Folkert W}",

year = "2020",

month = aug,

doi = "https://doi.org/10.1016/S2352-3026(20)30228-3",

language = "English",

volume = "7",

pages = "e557--e558",

journal = "Lancet. Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply

AU - Linschoten, Marijke

AU - Kamphuis, Janine Am

AU - Asselbergs, Folkert W

PY - 2020/8

Y1 - 2020/8

KW - Cyclophosphamide

KW - Doxorubicin

KW - Humans

KW - Lymphoma, Non-Hodgkin

KW - Prednisone

KW - Rituximab

KW - Vincristine

U2 - https://doi.org/10.1016/S2352-3026(20)30228-3

DO - https://doi.org/10.1016/S2352-3026(20)30228-3

M3 - Article

C2 - 32735830

SN - 2352-3026

VL - 7

SP - e557-e558

JO - Lancet. Haematology

JF - Lancet. Haematology

IS - 8

ER -